Biblio
Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy. 2024.
Targeting CD20-expressing malignant melanoma cells augments BRAF inhibitor killing. Br J Dermatol. 2024.
. Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model. Front Immunol. 2024;15:1366197.
Targeting Cervical Cancer Stem Cells by Phytochemicals. Curr Med Chem. 2024.
. Targeting DEP domain containing 1 in anaplastic thyroid carcinoma: Implications for stemness regulation and malignant phenotype suppression. Heliyon. 2024;10(5):e27150.
. Targeting EMSY-mediated methionine metabolism is a potential therapeutic strategy for triple-negative breast cancer. Cell Rep Med. 2024:101396.
. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology. Eur J Med Res. 2024;29(1):224.
. Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells. Int J Oncol. 2024;64(4).
. Targeting MYC at the intersection between cancer metabolism and oncoimmunology. Front Immunol. 2024;15:1324045.
. Targeting myostatin using quercetin as a media supplement to improve myogenesis for cultured meat production: An and study. Curr Res Food Sci. 2024;8:100678.
. Targeting nuclear receptor corepressors for reversible male contraception. Proc Natl Acad Sci U S A. 2024;121(9):e2320129121.
Targeting of membrane proteins with fluoronanogold probes for high-resolution correlative microscopy. Methods Cell Biol. 2024;187:57-72.
. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat Cancer. 2024.
Targeting Senescent Alveolar Epithelial Cells Using Engineered Mesenchymal Stem Cell-Derived Extracellular Vesicles To Treat Pulmonary Fibrosis. ACS Nano. 2024.
Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics. Int J Nanomedicine. 2024;19:3805-3825.
. Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells. Glycobiology. 2024.
. Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions. Recent Pat Anticancer Drug Discov. 2024.
. Targeting the "tumor microenvironment": RNA-binding proteins in the spotlight in colorectal cancer therapy. Int Immunopharmacol. 2024;131:111876.
. Targeting TNF/IL-17/MAPK pathway in h leukemia: effects of OUL35, KJ-Pyr-9, and CID44216842. Haematologica. 2024.
. Targeting Tumor Heterogeneity by Breaking a Stem Cell and Epithelial Niche Interaction Loop. Adv Sci (Weinh). 2024:e2307452.
. Targeting tumorous Circ-E-Cadherinencoded C-E-Cad inhibits the recruitment and function of breast cancer-associated myeloid-derived suppressor cells. Pharmacol Res. 2024:107204.
Targeting Wnt signaling for improved glioma immunotherapy. Front Immunol. 2024;15:1342625.
Taurine induces hormesis in multiple biological models: May have transformative implications for overall societal health. Chem Biol Interact. 2024:110930.
.